Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
Lets dive in to find out
Supplementary Table 2 (download XLSX Metabolism focused CRISPR genetic screens in SLC25A39 -knockout Jurkat and HEK 293T cells
Development of Cagrilintide, a Long-Acting Amylin Analogue [PMID: 34288673] Laboratory literature summary: Development of Cagrilintide, a Long-Acting Amylin Analogue
Start: 0.6 mg weekly for the first 2 weeks to assess tolerability
Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance
US$ 22.66
US$ 28.27
US$ 26.28
US$ 20.42
US$ 23.85
US$ 27.65
US$ 27.23
US$ 23.19
US$ 22.60
US$ 24.91
